Blood test may spot ALS sooner
NCT ID NCT07091799
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether measuring a specific receptor (P2X4) on blood cells can help diagnose amyotrophic lateral sclerosis (ALS), a severe nerve disease. Researchers will compare P2X4 levels in 50 people — some with ALS and some healthy volunteers. If the test works, it could lead to faster, more accurate diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- P2X4 receptor measurement in blood samples
- What this could lead to
- If successful, this could provide a simple blood test to help diagnose ALS earlier and more accurately.
- What could go wrong
- This is a small, early-stage study (50 participants) focused on finding a biomarker, not a treatment. The results may not be strong enough to change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS & OTHER NEUROMUSCULAR DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Pellegrin
RECRUITINGBordeaux, 33000, France